1 minute reading time (67 words)

Efficacy of Treatments for Opioid-induced Constipation: A Systematic Review and Meta-Analysis

Source: Clinical Gastroenterology and Hepatology
Abstract: Background & Aims: Opioid induced constipation (OIC) is a common problem in patients on chronic opioid therapy for cancer-related and non-cancer related pain. Approved treatments for OIC are methylnaltrexone, naloxone, naloxegol, alvimopan, naldemedine, and lubiprostone. Since a meta-analysis performed in 2014, 2 new agents have been approved by the Food and Drug Administration (FDA) for treatment of OIC (naloxegol and naldemedine).
Read more...

Related Posts

The AAPM Annual Meeting offers education and networking opportunities for all members of the pain care team.

Learn More